• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

The Lancet Infect Dis. Acute pneumonia and the cardiovascular system

Giuseppe

Emeritus
[Source: The Lancet Infectious Diseases, full page: (LINK). Abstract, edited.]

The Lancet, Early Online Publication, 16 January 2013
doi:10.1016/S0140-6736(12)61266-5

Acute pneumonia and the cardiovascular system

Original Text


Dr Vicente F Corrales-Medina MD a b, Prof Daniel M Musher MD c d, Svetlana Shachkina MD a b, Julio A Chirinos MD e f



Summary

Although traditionally regarded as a disease confined to the lungs, acute pneumonia has important effects on the cardiovascular system at all severities of infection. Pneumonia tends to affect individuals who are also at high cardiovascular risk. Results of recent studies show that about a quarter of adults admitted to hospital with pneumonia develop a major acute cardiac complication during their hospital stay, which is associated with a 60% increase in short-term mortality. These findings suggest that outcomes of patients with pneumonia can be improved by prevention of the development and progression of associated cardiac complications. Before this hypothesis can be tested, however, an adequate mechanistic understanding of the cardiovascular changes that occur during pneumonia, and their role in the trigger of various cardiac complications, is needed. In this Review, we summarise knowledge about the burden of cardiac complications in adults with acute pneumonia, the cardiovascular response to this infection, the potential effects of commonly used cardiovascular and anti-infective drugs on these associations, and possible directions for future research.


a Department of Medicine, University of Ottawa, ON, Canada- b Ottawa Hospital Research Institute, ON, Canada - c Departments of Medicine and Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA - d Medical Care Line, Infectious Disease Section, Michael E DeBakey VA Medical Center, Houston, TX, USA - e Division of Cardiology, University of Pennsylvania, PA, USA - f Philadelphia VA Medical Center, PA, USA

Correspondence to: Dr Vicente F Corrales-Medina, Department of Medicine, University of Ottawa, 1053 Carling Avenue, CPC 470, Ottawa, ON, K1Y 4E9, Canada
-
------
 
Back
Top Bottom